Alpha Teknova, Inc.

TKNO Healthcare Drug Manufacturers Specialty & Generic

Alpha Teknova, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $40.5 million, up 7.35% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 14.3%, free cash flow grew 74.2% and total debt rose 1.43%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

7.08 0.52 −6.84%
Market cap
$408.0M
P/E
0.0×
Fwd P/E
−13.3×
Dividend yield
—
F-score
5/9
Altman Z
1.83
Beneish M
−3.04
Dividend safety
n/a
Dec '17 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — 2 1 4 4 5
P/E ratio
— 64.73 64.73 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
— — — 9.08 0.90 0.56 4.95 1.83
P/S ratio
— 2.63 2.63 8.93 3.81 3.30 10.34 5.02
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
— 5.09 2.30 9.50 0.80 0.14 (0.61) (1.59)
Beneish M-Score
— — (1.64) (3.01) (3.43) (2.93) (2.70) (3.04)
P/Operating CF
— 37.48 37.48 (106.90) (19.66) (41.81) (417.02) (439.90)
P/B ratio
— 5.53 5.53 2.30 1.58 1.34 4.74 2.96
EV/Sales
— 2.55 2.55 6.88 3.38 2.93 9.89 4.91
EV/EBITDA
— 19.06 19.06 0.00 0.00 0.00 0.00 0.00
EV/FCF
— (19.63) (19.63) (8.77) (2.52) (4.05) (27.89) (20.33)
Current Ratio
— 2.76 4.14 13.07 5.62 5.14 3.82 4.58
Net Debt/EBITDA
— 3.22 (0.76) 8.41 0.39 0.52 0.86 0.75
Debt/Equity
— 0.00 0.00 0.08 0.24 0.15 0.16 0.19
ROE
— (9.70%) 4.10% (12.26%) (39.05%) (38.73%) (31.02%) (22.83%)
ROA
— (4.92%) 1.00% (8.55%) (29.78%) (26.19%) (21.62%) (15.52%)
ROIC
— 0.00% 25.04% (11.11%) (37.92%) (29.71%) (24.95%) (17.52%)
Return on Tangible Assets
— (9.42%) 2.71% (7.95%) (46.61%) (42.20%) (34.59%) (25.12%)
Average Days of Receivables
— 52.45 70.44 57.92 37.74 39.28 41.70 41.60
Earnings Yield
— 1.54% 1.54% (4.65%) (30.07%) (30.53%) (7.07%) (8.68%)
Free Cash Flow Yield
— (4.94%) (4.94%) (8.79%) (35.20%) (21.96%) (3.43%) (4.82%)
Free Cash Flow per Share
— 0.09 (0.82) (1.80) (1.98) (0.83) (0.29) (0.18)
Book value per Share
— 1.86 4.66 8.90 3.56 2.83 1.76 1.29
Free Cash Flow
— 2.41 (2.96) (28.95) (55.55) (26.55) (13.39) (9.79)
EV/EBIT
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates